These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 22110136)
21. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds? Gumperz JE Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260 [TBL] [Abstract][Full Text] [Related]
22. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140 [TBL] [Abstract][Full Text] [Related]
23. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy. Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790 [TBL] [Abstract][Full Text] [Related]
24. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells. Gerth E; Mattner J Front Immunol; 2019; 10():1449. PubMed ID: 31293596 [TBL] [Abstract][Full Text] [Related]
25. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393 [TBL] [Abstract][Full Text] [Related]
26. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. Yu ED; Girardi E; Wang J; Zajonc DM J Immunol; 2011 Sep; 187(5):2079-83. PubMed ID: 21810611 [TBL] [Abstract][Full Text] [Related]
27. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding. Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730 [TBL] [Abstract][Full Text] [Related]
28. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805 [TBL] [Abstract][Full Text] [Related]
29. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner. Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315 [TBL] [Abstract][Full Text] [Related]
30. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands. Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779 [TBL] [Abstract][Full Text] [Related]
31. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809 [TBL] [Abstract][Full Text] [Related]
32. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603 [TBL] [Abstract][Full Text] [Related]